FMC
23
-3
ZBH
65
3
MCO
71
-7
WMB
68
2
D
40
2
CMA
61
-3
PGR
59
-3
IR
63
-3
HSY
31
-6
ACN
47
-5
PEP
39
-9
EQT
51
-3
SWK
50
-5
PCAR
56
-5
MO
60
-2
DVN
14
-6
CMG
66
-4
BDX
56
10
PLD
45
-5
GT
56
-3
FMC
23
-3
ZBH
65
3
MCO
71
-7
WMB
68
2
D
40
2
CMA
61
-3
PGR
59
-3
IR
63
-3
HSY
31
-6
ACN
47
-5
PEP
39
-9
EQT
51
-3
SWK
50
-5
PCAR
56
-5
MO
60
-2
DVN
14
-6
CMG
66
-4
BDX
56
10
PLD
45
-5
GT
56
-3
Financhill
Back

CytoMed Therapeutics 10K Form

Sell
50

GDTC
CytoMed Therapeutics

Last Price:
1.95
Seasonality Move:
-37.85%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GDTC News And Ratings

See the #1 stock for the next 7 days that we like better than GDTC

GDTC Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.65
Price / Book: 3.35

Profitability

EPS (TTM): -0.19340
Net Income (TTM): $-2.27M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

CytoMed Therapeutics Earnings Forecast

Key CytoMed Therapeutics Financial Ratios

  • The Interest Expense is -1.24% of Operating Income.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

CytoMed Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GDTC
Website: w2.cytomed.sg

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GDTC Technical Analysis vs Fundamental Analysis

Sell
50
CytoMed Therapeutics (GDTC) is a Sell

Is CytoMed Therapeutics a Buy or a Sell?